Literature DB >> 18955457

Body-mass index and progression of hepatitis B: a population-based cohort study in men.

Ming-Whei Yu1, Wei-Liang Shih, Chih-Lin Lin, Chun-Jen Liu, Jhih-Wei Jian, Keh-Sung Tsai, Chien-Jen Chen.   

Abstract

PURPOSE: To determine prospectively whether body-mass index (BMI) is associated with liver-related morbidity and mortality among male hepatitis B virus (HBV) carriers. PATIENTS AND METHODS: We performed a prospective study of 2,903 male HBV surface antigen-positive government employees who were free of cancer at enrollment between 1989 and 1992. Main outcome measures included ultrasonography, biochemical tests, incident hepatocellular carcinoma (HCC), and liver-related death.
RESULTS: During mean follow-up of 14.7 years, 134 developed HCC and 92 died as a result of liver-related causes. In Cox proportional hazards models adjusting for age, number of visits, diabetes, and use of alcohol and tobacco, the hazard ratios for incident HCC were 1.48 (95% CI, 1.04 to 2.12) in overweight men (BMI between 25.0 and 29.9 kg/m(2)) and 1.96 (95% CI, 0.72 to 5.38) in obese men (BMI >or= 30.0 kg/m(2)), compared with normal-weight men (BMI between 18.5 and 24.9 kg/m(2)). Liver-related mortality had adjusted hazard ratios of 1.74 (95% CI, 1.15 to 2.65) in overweight men and 1.50 (95% CI, 0.36 to 6.19) in obese men. Excess BMI was also associated with the occurrence of fatty liver and cirrhosis detected by ultrasonography, as well as elevated ALT and gamma-glutamyltransferase (GGT) activity during follow-up. The association of BMI with GGT was stronger than with ALT, and elevated GGT activity and cirrhosis were the strongest predictors for incident HCC and liver-related death.
CONCLUSION: This longitudinal cohort study indicates that excess body weight is involved in the transition from healthy HBV carrier state to HCC and liver-related death among men.

Entities:  

Mesh:

Year:  2008        PMID: 18955457     DOI: 10.1200/JCO.2008.16.1075

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  38 in total

Review 1.  Association between hepatitis B and metabolic syndrome: Current state of the art.

Authors:  Peter Jarcuska; Sylvia Drazilova; Jan Fedacko; Daniel Pella; Martin Janicko
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

2.  Effect of Metabolic Syndrome on the Clinical Outcomes of Chronic Hepatitis B Patients with Nucleos(t)ide Analogues Treatment.

Authors:  Nam Hee Kim; Yong Kyun Cho; Byung Ik Kim; Hong Joo Kim
Journal:  Dig Dis Sci       Date:  2018-06-12       Impact factor: 3.199

3.  Adiponectin receptor expression predicts favorable prognosis in cases of hepatocellular carcinoma.

Authors:  Eun Shin; Young-Dong Yu; Dong-Sik Kim; Nam Hee Won
Journal:  Pathol Oncol Res       Date:  2014-03-12       Impact factor: 3.201

4.  Association of High Body Mass Index and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection: A Korean Population-Based Cohort Study.

Authors:  Kyuwoong Kim; Seulggie Choi; Sang Min Park
Journal:  JAMA Oncol       Date:  2018-05-01       Impact factor: 31.777

5.  Hepatitis B virus infection and risk of non-alcoholic fatty liver disease: A population-based cohort study.

Authors:  Liguo Zhu; Jie Jiang; Xiangjun Zhai; Aileen Baecker; Hong Peng; Jiao Qian; MingHao Zhou; Ci Song; Yan Zhou; Jianfang Xu; Hongjian Liu; Dong Hang; Zhibin Hu; Hongbin Shen; Zuo-Feng Zhang; Fengcai Zhu
Journal:  Liver Int       Date:  2018-08-19       Impact factor: 5.828

6.  Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort.

Authors:  Li-Ting Chao; Chih-Feng Wu; Feng-Yu Sung; Chih-Lin Lin; Chun-Jen Liu; Chi-Jung Huang; Keh-Sung Tsai; Ming-Whei Yu
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

7.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

Review 8.  Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link.

Authors:  Abby B Siegel; Andrew X Zhu
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

Review 9.  Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.

Authors:  Claus Niederau
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

Review 10.  NAFLD, NASH and liver cancer.

Authors:  Gregory A Michelotti; Mariana V Machado; Anna Mae Diehl
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-10-01       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.